1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase II Clinical Study of SHR-A1904 Monotherapy in Second-Line or Later Treatment of Advanced Neuroendocrine CarcinomaAdvanced Neuroendocrine CarcinomaNot yet recruitingPhase 22026-04-09NCT07520357